1h Free Analyst Time
The pulmonary embolism therapeutics market is forecasted to grow by USD 10,898.47 mn during 2022-2027, accelerating at a CAGR of 9.52% during the forecast period. The report on the pulmonary embolism therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing risk of adverse health conditions, increase in geriatric population, and rise in research and development activities for pulmonary embolism therapeutics.
The pulmonary embolism therapeutics market is segmented as below:
By Application
- Hospitals
- Ambulatory surgical centers
- Research institutes
By Route Of Administration
- Oral
- Parenteral
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the pulmonary embolism therapeutics market covers the following areas:
- Pulmonary embolism therapeutics market sizing
- Pulmonary embolism therapeutics market forecast
- Pulmonary embolism therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global pulmonary embolism therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global pulmonary embolism therapeutics market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 ROA Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - ROA Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Hospitals - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
6.4 Ambulatory surgical centers - Market size and forecast 2022-2027
Exhibit 38: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
6.5 Research institutes - Market size and forecast 2022-2027
Exhibit 42: Chart on Research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Research institutes - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ million)
Exhibit 47: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 48: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 49: Data Table on Route of Administration - Market share 2022-2027 (%)
7.2 Comparison by Route of Administration
Exhibit 50: Chart on Comparison by Route of Administration
Exhibit 51: Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2022-2027
Exhibit 52: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Oral - Year-over-year growth 2022-2027 (%)
7.4 Parenteral - Market size and forecast 2022-2027
Exhibit 56: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Route of Administration
Exhibit 60: Market opportunity by Route of Administration ($ million)
Exhibit 61: Data Table on Market opportunity by Route of Administration ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 France - Market size and forecast 2022-2027
Exhibit 87: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on France - Year-over-year growth 2022-2027 (%)
9.9 Norway - Market size and forecast 2022-2027
Exhibit 91: Chart on Norway - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Norway - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Norway - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Norway - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product/Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 115: Amgen Inc. - Overview
Exhibit 116: Amgen Inc. - Product/Service
Exhibit 117: Amgen Inc. - Key offerings
12.5 Anthos Therapeutics
Exhibit 118: Anthos Therapeutics - Overview
Exhibit 119: Anthos Therapeutics - Product/Service
Exhibit 120: Anthos Therapeutics - Key offerings
12.6 Bayer AG
Exhibit 121: Bayer AG - Overview
Exhibit 122: Bayer AG - Business segments
Exhibit 123: Bayer AG - Key news
Exhibit 124: Bayer AG - Key offerings
Exhibit 125: Bayer AG - Segment focus
12.7 Boehringer Ingelheim International GmbH
Exhibit 126: Boehringer Ingelheim International GmbH - Overview
Exhibit 127: Boehringer Ingelheim International GmbH - Business segments
Exhibit 128: Boehringer Ingelheim International GmbH - Key news
Exhibit 129: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 130: Boehringer Ingelheim International GmbH - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 131: Bristol Myers Squibb Co. - Overview
Exhibit 132: Bristol Myers Squibb Co. - Product/Service
Exhibit 133: Bristol Myers Squibb Co. - Key news
Exhibit 134: Bristol Myers Squibb Co. - Key offerings
12.9 Daiichi Sankyo Co. Ltd.
Exhibit 135: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 136: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibit 137: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 138: Daiichi Sankyo Co. Ltd. - Key offerings
12.10 Eli Lilly and Co.
Exhibit 139: Eli Lilly and Co. - Overview
Exhibit 140: Eli Lilly and Co. - Product/Service
Exhibit 141: Eli Lilly and Co. - Key news
Exhibit 142: Eli Lilly and Co. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Gilead Sciences Inc.
Exhibit 148: Gilead Sciences Inc. - Overview
Exhibit 149: Gilead Sciences Inc. - Product/Service
Exhibit 150: Gilead Sciences Inc. - Key news
Exhibit 151: Gilead Sciences Inc. - Key offerings
12.13 Inari Medical Inc.
Exhibit 152: Inari Medical Inc. - Overview
Exhibit 153: Inari Medical Inc. - Product/Service
Exhibit 154: Inari Medical Inc. - Key offerings
12.14 Johnson and Johnson Services Inc.
Exhibit 155: Johnson and Johnson Services Inc. - Overview
Exhibit 156: Johnson and Johnson Services Inc. - Business segments
Exhibit 157: Johnson and Johnson Services Inc. - Key news
Exhibit 158: Johnson and Johnson Services Inc. - Key offerings
Exhibit 159: Johnson and Johnson Services Inc. - Segment focus
12.15 Pfizer Inc.
Exhibit 160: Pfizer Inc. - Overview
Exhibit 161: Pfizer Inc. - Product/Service
Exhibit 162: Pfizer Inc. - Key news
Exhibit 163: Pfizer Inc. - Key offerings
12.16 Sanofi
Exhibit 164: Sanofi - Overview
Exhibit 165: Sanofi - Business segments
Exhibit 166: Sanofi - Key news
Exhibit 167: Sanofi - Key offerings
Exhibit 168: Sanofi - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global pulmonary embolism therapeutics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - ROA Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Application - Market share 2022-2027 (%)
Exhibits 31: Data Table on Application - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Research institutes - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Research institutes - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by Application ($ million)
Exhibits 47: Data Table on Market opportunity by Application ($ million)
Exhibits 48: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits 49: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Route of Administration
Exhibits 51: Data Table on Comparison by Route of Administration
Exhibits 52: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits 60: Market opportunity by Route of Administration ($ million)
Exhibits 61: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Norway - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Norway - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Norway - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Norway - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2022 and 2027
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: AbbVie Inc. - Overview
Exhibits 112: AbbVie Inc. - Product/Service
Exhibits 113: AbbVie Inc. - Key news
Exhibits 114: AbbVie Inc. - Key offerings
Exhibits 115: Amgen Inc. - Overview
Exhibits 116: Amgen Inc. - Product/Service
Exhibits 117: Amgen Inc. - Key offerings
Exhibits 118: Anthos Therapeutics - Overview
Exhibits 119: Anthos Therapeutics - Product/Service
Exhibits 120: Anthos Therapeutics - Key offerings
Exhibits 121: Bayer AG - Overview
Exhibits 122: Bayer AG - Business segments
Exhibits 123: Bayer AG - Key news
Exhibits 124: Bayer AG - Key offerings
Exhibits 125: Bayer AG - Segment focus
Exhibits 126: Boehringer Ingelheim International GmbH - Overview
Exhibits 127: Boehringer Ingelheim International GmbH - Business segments
Exhibits 128: Boehringer Ingelheim International GmbH - Key news
Exhibits 129: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 130: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 131: Bristol Myers Squibb Co. - Overview
Exhibits 132: Bristol Myers Squibb Co. - Product/Service
Exhibits 133: Bristol Myers Squibb Co. - Key news
Exhibits 134: Bristol Myers Squibb Co. - Key offerings
Exhibits 135: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 136: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibits 137: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 138: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 139: Eli Lilly and Co. - Overview
Exhibits 140: Eli Lilly and Co. - Product/Service
Exhibits 141: Eli Lilly and Co. - Key news
Exhibits 142: Eli Lilly and Co. - Key offerings
Exhibits 143: F. Hoffmann La Roche Ltd. - Overview
Exhibits 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 145: F. Hoffmann La Roche Ltd. - Key news
Exhibits 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 148: Gilead Sciences Inc. - Overview
Exhibits 149: Gilead Sciences Inc. - Product/Service
Exhibits 150: Gilead Sciences Inc. - Key news
Exhibits 151: Gilead Sciences Inc. - Key offerings
Exhibits 152: Inari Medical Inc. - Overview
Exhibits 153: Inari Medical Inc. - Product/Service
Exhibits 154: Inari Medical Inc. - Key offerings
Exhibits 155: Johnson and Johnson Services Inc. - Overview
Exhibits 156: Johnson and Johnson Services Inc. - Business segments
Exhibits 157: Johnson and Johnson Services Inc. - Key news
Exhibits 158: Johnson and Johnson Services Inc. - Key offerings
Exhibits 159: Johnson and Johnson Services Inc. - Segment focus
Exhibits 160: Pfizer Inc. - Overview
Exhibits 161: Pfizer Inc. - Product/Service
Exhibits 162: Pfizer Inc. - Key news
Exhibits 163: Pfizer Inc. - Key offerings
Exhibits 164: Sanofi - Overview
Exhibits 165: Sanofi - Business segments
Exhibits 166: Sanofi - Key news
Exhibits 167: Sanofi - Key offerings
Exhibits 168: Sanofi - Segment focus
Exhibits 169: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 170: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibits 171: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 172: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 173: Inclusions checklist
Exhibits 174: Exclusions checklist
Exhibits 175: Currency conversion rates for US$
Exhibits 176: Research methodology
Exhibits 177: Validation techniques employed for market sizing
Exhibits 178: Information sources
Exhibits 179: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global pulmonary embolism therapeutics market: AbbVie Inc., Amgen Inc., Anthos Therapeutics, argenx SE, Astellas Pharma Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Inari Medical Inc., Johnson and Johnson Services Inc., Medtronic Plc, Novartis AG, Pfizer Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advancements in healthcare and medical sector.'
According to the report, one of the major drivers for this market is the growing risk of adverse health conditions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Anthos Therapeutics
- argenx SE
- Astellas Pharma Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Daiichi Sankyo Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- Inari Medical Inc.
- Johnson and Johnson Services Inc.
- Medtronic Plc
- Novartis AG
- Pfizer Inc.
- Sanofi
- Takeda Pharmaceutical Co. Ltd.
- Viatris Inc.
